WallStreetZenWallStreetZen

NASDAQ: ACST
Acasti Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ACST

Based on 2 analysts offering 12 month price targets for Acasti Pharma Inc.
Min Forecast
$2.40+340.37%
Avg Forecast
$2.45+349.54%
Max Forecast
$2.50+358.72%

Should I buy or sell ACST stock?

Based on 2 analysts offering ratings for Acasti Pharma Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACST stock forecasts and price targets.

ACST stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
EF Hutton
Bottom 4%
4
Strong BuyReiterates$2.50+358.72%2023-02-15
HC Wainwright & Co.
Bottom 8%
8
BuyInitiates Coverage On$2.40+340.37%2022-12-15

1 of 1

Forecast return on equity

Is ACST forecast to generate an efficient return?
Company
8.76%
Industry
0.08%
Market
72.91%
ACST's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ACST forecast to generate an efficient return on assets?
Company
7.26%
Industry
0.1%
ACST is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ACST vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACST$0.55$2.45+349.54%Strong Buy
HARP$0.66$4.83+636.74%Buy
LPCN$4.74N/AN/A
VBIV$2.88$6.00+108.70%Buy
NTRB$2.99N/AN/A
View Top Biotech Stocks

Acasti Pharma Stock Forecast FAQ

Is Acasti Pharma Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ACST) stock is to Strong Buy ACST stock.

Out of 2 analysts, 1 (50%) are recommending ACST as a Strong Buy, 1 (50%) are recommending ACST as a Buy, 0 (0%) are recommending ACST as a Hold, 0 (0%) are recommending ACST as a Sell, and 0 (0%) are recommending ACST as a Strong Sell.

If you're new to stock investing, here's how to buy Acasti Pharma stock.

What is ACST's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: ACST) forecast ROE is 8.76%, which is considered weak.

What is ACST's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ACST price target, the average ACST price target is $2.45, with the highest ACST stock price forecast at $2.50 and the lowest ACST stock price forecast at $2.40.

On average, Wall Street analysts predict that Acasti Pharma's share price could reach $2.45 by Feb 15, 2024. The average Acasti Pharma stock price prediction forecasts a potential upside of 349.54% from the current ACST share price of $0.55.

What is ACST's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: ACST) forecast ROA is 7.26%, which is higher than the forecast US Biotechnology industry average of 0.1%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.